Skip to content

Clinical trials

Hyperlipidemias trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Country / region: Hungary Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20062
20072
20112
20121
20135
20212
20222
20232
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting3
Recruiting3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Novartis Pharmaceuticals4
Amgen3
Pfizer3
Takeda2
89bio, Inc.1
Eli Lilly and Company1
Federico II University1
Genentech, Inc.1
Ionis Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias25
Dyslipidemias8
Hypercholesterolemia8
Cardiovascular Diseases6
Hypertriglyceridemia3
Myocardial Infarction3
Stroke3
Atherosclerosis2
Coronary Artery Disease2
Diabetes Mellitus2

Trials

Showing 76 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.